PFE — Pfizer, Inc. Common Stock
Session close: $30.79. Regular-session share volume: 38,140,124. Change from previous close: +2.63%.
News sources
Company news RBC Capital Maintains Sector Perform on Pfizer, Raises Price Target to $28 · Company news Goldman Sachs Adjusts Pfizer Price Target to $28 · Company news United Therapeutics Announces $525 Million Royalty Buydown with Pfizer Subsidiary Arena Pharmaceuticals · Company news Amazon, Pfizer, Eaton And A Financial Stock On CNBC’s ‘Final Trades’ · Company news CNBC Halftime Report Final Trades: BlackRock, Eaton, Pfizer, Amazon · Company news Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings · Company news Pfizer Q3 2026 Earnings Call Transcript · Company news Pfizer Just Raised Guidance. The Bigger Test Comes Next · Company news Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity Market · Company news Pfizer Inc (PFE) (Q3 2026) Earnings Call Highlights: Raised Guidance, Cost Savings Momentum, ... · Company news How To Earn $500 A Month From Pfizer Stock Ahead Of Q3 Earnings · Company news Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs. · Company news Apple, Palantir, Pfizer, Marvell, AMD, Bloom Energy, Gartner, and More Stocks That Explain Today’s Market · Market context — Mentions PFE in the article text. Nasdaq Jumps Over 200 Points as Chip Stocks Gain: Fear & Greed Index Remains in ‘Extreme Fear’ Zone · Company mentioned — Mentions PFE in the article text. United Therapeutics Announces Buydown of Ralinepag Royalty